Jump to: Page Content, Section Navigation, Site Navigation, Site Search, Account Information, or Site Tools.
|
|
Sci. Signal., 9 August 2011 RESEARCH ARTICLESEditor's Summary Receptor MemoryDrugs that activate the β2-adrenergic receptor (β2AR), or β2AR agonists, are used to treat various conditions, such as asthma and premature labor contractions. Frequently occurring polymorphisms that result in amino acid substitutions at position 16 in the β2AR have been correlated to different responses to these drugs. Ahles et al. (see also the Perspective by Insel) found that the β2AR responded differently to repeated drug stimulation, a phenomenon the authors call receptor "memory." A variant of the β2AR with arginine at position 16 was slower in response to repeated stimulation. In contrast, a polymorphic variant of β2AR with glycine at position 16 showed faster activation when repeatedly stimulated, an effect that was associated with increased production of a downstream signaling molecule. The authors propose that these polymorphism-specific responses of the β2AR to continued stimulation may contribute to individual variation in responses to β2AR agonists.
Citation: A. Ahles, F. Rochais, T. Frambach, M. Bünemann, S. Engelhardt, A Polymorphism-Specific "Memory" Mechanism in the β2-Adrenergic Receptor. Sci. Signal. 4, ra53 (2011). The editors suggest the following Related Resources on Science sites:In Science Signaling
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
|
Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882